Product Wiki · Recalls · EU Safety Gate (RAPEX)

Gyermek Esokopeny — recall SR/04157/25

EU Safety Gate (RAPEX) · Lithuania · 2025-11-28 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/04157/25
Date of alert
2025-11-28
Country / jurisdiction
Lithuania
Risk level
Serious risk
Risk type
Chemical, Environment
Product category
Clothing, textiles and fashion items
Product type
Rain coat
🔴 Serious hazard — Reported risk: The product contains an excessive amount of Perfluorooctanic acid (PFOA), their salts and related substances (measured value: 13.6 mg/kg). These substances are carcinogenic and pose a risk to the environment. Moreover, the product contains an excessive amount of Perfluoroalkyl carboxylic acids (PFCAs) and related substances (measured value: 12.9 mg/kg). Perfluoroalkyl carboxylic acids (PFCAs) can cause developmental and reproductive toxic effects and are carcinogenic.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Withdrawal of the product from the market
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10096800

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.